HCW Biologics Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
HCW Biologics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • HCW Biologics Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$15.3M, a 255% decline year-over-year.
  • HCW Biologics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$38.4M, a 105% decline year-over-year.
  • HCW Biologics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$25M, a 67.7% decline from 2022.
  • HCW Biologics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.9M, a 15.8% decline from 2021.
  • HCW Biologics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.9M, a 122% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$25M -$10.1M -67.7% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-05-15
2022 -$14.9M -$2.04M -15.8% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-15
2021 -$12.9M -$7.06M -122% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$5.8M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.